VIRION Mid Term Consortium meeting

VIRION – year 2 consortium meeting

September 15 2017, Amsterdam


During the VIRION project’s recent mid term meeting held on the 13 and 14 of September, the consortium partners met to discuss the progress made in the program. The overall program was presented and discussed with the H2020 REA representatives.

A highly interactive workshop program was organized on the 13th of September with the program partners Hyphen Projects, Diamond Pharma, Quintes Consultancy, VUmc, TILT biotherapeutics and ORCA Therapeutics. The workshop programme covered aspected in biobusiness, entrepreneurship, Quality in R&D and (pre)clinical development and regulatory affairs.

Partners and REA representatives stated their positive view on the current progress and development of the VIRION program.

EU flagThis project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 643130.